Cargando…
Positive expression of NR6A1/CT150 as a predictor of biochemical recurrence-free survival in prostate cancer patients
NR6A1/CT150, as an orphan receptor, is a novel member of the cancer-testis (CT) antigen family. Here, we investigated the expression and function of NR6A1 and its underlying mechanisms in prostate cancer (PCa) patients who underwent radical prostatectomy. A total of 303 cases of prostate cancer afte...
Autores principales: | Cheng, Gong, Wang, Shangqian, Li, Xiao, Li, Shuang, Zheng, Yang, Zhang, Lei, Bao, Meiling, Liang, Chao, Huang, Zhengkai, Liu, Yiyang, Qin, Chao, Shao, Pengfei, Li, Jie, Hua, Lixin, Yin, Changjun, Wang, Zengjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610014/ https://www.ncbi.nlm.nih.gov/pubmed/28969082 http://dx.doi.org/10.18632/oncotarget.11749 |
Ejemplares similares
-
ALDH1A3 serves as a predictor for castration resistance in prostate cancer patients
por: Wang, Shangqian, et al.
Publicado: (2020) -
TRIM36, a novel androgen-responsive gene, enhances anti-androgen efficacy against prostate cancer by inhibiting MAPK/ERK signaling pathways
por: Liang, Chao, et al.
Publicado: (2018) -
CD151 promotes cell metastasis via activating TGF-β1/Smad signaling in renal cell carcinoma
por: Yu, Yajie, et al.
Publicado: (2018) -
MicroRNA-126 inhibits proliferation and metastasis in prostate cancer via regulation of ADAM9
por: Hua, Yibo, et al.
Publicado: (2018) -
Retroperitoneal laparoscopic partial nephrectomy with segmental renal artery clamping for cancer of the left upper calyx: a case report
por: Yu, Yajie, et al.
Publicado: (2017)